Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain Amyloidosis

Circ Cardiovasc Imaging. 2016 Oct;9(10):e004770. doi: 10.1161/CIRCIMAGING.116.004770.

¹ From Department of Internal Medicine, Section of Cardiovascular Medicine (D.J.H., D.L.D., S.H., H.R.M., J.L.M., L.A.B.), Yale Cancer Center, Smilow Cancer Hospital at Yale-New Haven; and Department of Internal Medicine, Section of Hematology (S.E.S.), and Department of Radiology and Biomedical Imaging (D.L.D., S.H., H.R.M., L.A.B.), Yale School of Medicine, New Haven, CT.
² From Department of Internal Medicine, Section of Cardiovascular Medicine (D.J.H., D.L.D., S.H., H.R.M., J.L.M., L.A.B.), Yale Cancer Center, Smilow Cancer Hospital at Yale-New Haven; and Department of Internal Medicine, Section of Hematology (S.E.S.), and Department of Radiology and Biomedical Imaging (D.L.D., S.H., H.R.M., L.A.B.), Yale School of Medicine, New Haven, CT. lauren.baldassarre@yale.edu.

No abstract available

Keywords: T1 mapping; amyloid; cardiovascular MRI; noncontrast; precontrast; serial.

Publication types